(Adnkronos) - “Le terapie per la linfatica cronica stanno diventando sempre di più e sempre più efficaci negli ultimi anni, c'è stata proprio una vera e propria rivoluzione che ha trasformato la terapia di questa malattia da una chemio immunoterapia aggressiva a terapia intelligente”. Così, Paolo Sportoletti, sezione Ematologia del dipartimento di Medicina e chirurgia dell’università di Perugia, a margine del convegno nazionale “Leucemia Linfatica Cronica: tempo per vivere” promosso da AbbVie, che ha riunito a Roma clinici ed esperti per fare il punto sullo stato dell’arte rispetto alle nuove prospettive dei pazienti.
Category
🗞
NewsTranscript
00:00 (upbeat music)
00:03 (speaking in foreign language)
00:07 (coughing)
00:09 (speaking in foreign language)
00:13 (coughing)
00:15 (speaking in foreign language)
00:19 (coughing)
00:22 (speaking in foreign language)
00:25 (speaking in foreign language)
00:29 (speaking in foreign language)
00:33 (speaking in foreign language)
00:37 (speaking in foreign language)
00:41 (speaking in foreign language)
00:45 (speaking in foreign language)
00:49 (speaking in foreign language)
00:53 (speaking in foreign language)
00:57 (speaking in foreign language)
01:01 (speaking in foreign language)
01:05 (speaking in foreign language)
01:09 (speaking in foreign language)
01:13 (speaking in foreign language)
01:16 (speaking in foreign language)
01:20 (speaking in foreign language)
01:24 (speaking in foreign language)
01:28 (speaking in foreign language)
01:32 (speaking in foreign language)
01:36 (speaking in foreign language)
01:40 (speaking in foreign language)
01:44 (speaking in foreign language)
01:48 (speaking in foreign language)
01:52 especially the very old ones.